C170 (Darifenacin Hydrobromide Extended-Release 7.5 mg)
Pill with imprint C170 is Yellow, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Par Pharmaceutical, Inc..
Darifenacin is used in the treatment of overactive bladder; urinary incontinence; urinary frequency and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C170
Darifenacin Hydrobromide Extended-Release
- Imprint
- C170
- Strength
- 7.5 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0170
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
hypromellose 2208 (3 mPa.s),
lactose monohydrate,
magnesium stearate,
polyvinyl alcohol,
magnesium silicate,
polyethylene glycol,
titanium dioxide,
D&C Yellow No. 10,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Related Images for "C170"
More about darifenacin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 24 Reviews
- Drug class: urinary antispasmodics
Consumer resources
- Other brands
- Enablex
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.